Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
The Role of Surgical Resection AND Stereotactic Radiosurgery in Primary Central Nervous System -Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT07007611. IPD Sharing: NO. Countries: 0. Publications: 0.
Clinical Trial of HY004 Cell Injection in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT06005649. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study of SGN-40 in Combination With Rituximab in Patients With CD20-Positive, Follicular and Marginal Zone B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00556699. IPD Sharing: Not stated. Countries: 0. Publications: 0.
RHCACD20MA (HS006) Combined With CHOP (Hi-CHOP) in Patients With Previously Untreated Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT03485118. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Multicenter, Phase 2 Study Evaluating the Value of Radiotherapy in Advanced Diffuse Large B-cell Lymphoma Patients With Extranodal Involvement and Large Tumors Undergoing Immunochemotherapy for PET-
ClinicalTrials.gov study NCT05874778. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL)
ClinicalTrials.gov study NCT00927797. IPD Sharing: Not stated. Countries: 0. Publications: 0.
B-Cell Reconstitution After Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT04682314. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
A Study of GC019F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL
ClinicalTrials.gov study NCT04595162. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive Chemotherapy
ClinicalTrials.gov study NCT07335094. IPD Sharing: NO. Countries: 0. Publications: 0.
Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT05309213. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Chronic B-cell Lymphocytic Leukemia or Small Lymphoc
ClinicalTrials.gov study NCT02556346. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Zanubrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancies
ClinicalTrials.gov study NCT07283965. IPD Sharing: NO. Countries: 0. Publications: 0.
CD19 CAR and PD-1 Knockout Engineered T Cells for CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma
ClinicalTrials.gov study NCT03298828. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Biomarkers in Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab
ClinicalTrials.gov study NCT01131208. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma
ClinicalTrials.gov study NCT03261349. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma
ClinicalTrials.gov study NCT05535673. IPD Sharing: NO. Countries: 0. Publications: 0.
Clinical Study of Novel TLR2-Containing CAR-T Cells Targeting CD19 and CD22 for Relapsed/Refractory B-ALL and NHL
ClinicalTrials.gov study NCT06879262. IPD Sharing: NO. Countries: 0. Publications: 0.
A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.
ClinicalTrials.gov study NCT06927466. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies
ClinicalTrials.gov study NCT06894693. IPD Sharing: Not stated. Countries: 0. Publications: 0.
SCH 727965 in Patients With Mantle Cell Lymphoma or B-Cell Chronic Lymphocytic Leukemia (Study P04715)
ClinicalTrials.gov study NCT00871546. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.